comparing adjuvant tamoxifen with ovarian function suppression via exomestane to tamoxifen alone
Published 6 years ago • 386 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
5:44
breast cancer: adjuvant exemestane combined with ovarian function suppression better than tamoxifen
-
6:13
adjuvant exemestane more effective than tamoxifen (combined with ofs) in women with breast cancer
-
1:28
comment: combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers
-
19:14
ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases
-
7:25
ovarian suppression with tamoxifen reduced recurrence for some women with pbc
-
10:05
gs2-05: "randomized comparison of adjuvant aromatase inhibitor exemestane (e) plus ovarian..."
-
2:07
ovarian suppression plus ai treatment can have major adverse events
-
3:50
temporary ovarian suppression hormone analogue may preserve fertility during breast cancer chemo
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
6:28
ovarian suppression in metastatic hr breast cancer
-
0:53
beth overmoyer discusses role of ovarian suppression in young, high-risk women
-
4:55
ovarian function suppression for breast cancer: lupron or zoladex- monthly or every 3 months?
-
8:11
san antonio breast cancer symposium 2008: big 1-98: letrozole vs tamoxifen
-
1:25
dr. debu tripathy on 10 versus 5 years of adjuvant tamoxifen
-
3:11
ovarian function suppression in premenopausal women with breast cancer
-
1:41
new hope for women who are tamoxifen-resistant
-
1:27
q&a "what is the difference between aromatase inhibitors and tamoxifen?"
-
3:34
partridge: ovarian function suppression in young breast cancer patients
-
0:53
final results of the phase 3 data trial assessing aromatase inhibition in hr breast cancer